Skip to main content
SpringerLink
Log in
Book cover

Ultraviolet Light in Human Health, Diseases and Environment pp 193–205Cite as

Vitamin D and Type 2 Diabetes Mellitus

  • Chapter
  • First Online:

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 996))

Abstract

Type 2 diabetes mellitus (T2DM) has become a significant global health care problem and its reported incidence is increasing at an alarming rate. Despite the improvement in therapy and development of new drugs, treatment still remains insufficient especially due to the associated side effects of most available drugs. Efforts are continuing toward disease prevention and search for safer drugs. Conflicting evidence is associating low levels of vitamin D in the body to T2DM and as such studies have been conducted to test the effect of vitamin D levels on incidence of diabetes, diabetic control as well as diabetic complications.

Despite the conflicting evidence, vitamin D replacement seems to have some beneficial effect on the many aspects of diabetes: incidence, control and complications. Further long term and more convincing controlled trials are required in order to draw firmer conclusions on this beneficial role of vitamin D treatment on T2DM.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. International Diabetes Federation (2013) IDF Diabetes Atlas, 6th edn. International Diabetes Federation, Brussels, pp 32–49

    Google Scholar 

  2. Chagas CE, Borges MC, Martini LA, Rogero MM (2012) Focus on vitamin D, inflammation and type 2 diabetes. Forum Nutr 4:52–67

    CAS  Google Scholar 

  3. Campbell IT, Jarrett RJ, Keen H (1975) Diurnal and seasonal variation in oral glucose tolerance: studies in the Antarctic. Diabetologia 11:139–145

    Article  CAS  PubMed  Google Scholar 

  4. DeLuca HF (2004) Overview of general physiologic features and functions of vitamin D. Am J ClinNutr 80(6Suppl):1689S–1696S

    CAS  Google Scholar 

  5. Tsiaras WG, Weinstoc MA (2011) Factors influencing vitamin D status. Acta Derm Venereol 91:115–124

    Article  PubMed  Google Scholar 

  6. Blum M, Dolnikowski G, Seyoum E, Harris SS, Booth SL, Peterson J, Saltzman E, Dawson-Hughes B (2008) Vitamin D(3) in fat tissue. Endocrine 33:90–94

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Issa C, Azar S, Zantout M (2014) Vitamin D replacement and type 2 diabetes mellitus. Curr Diabetes Rev 10(5):7–16

    Google Scholar 

  8. Ross AC, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS et al (2011) Institute of medicine (US) committee to review dietary reference intakes for vitamin D and calcium. In: Ross AC, Taylor CL, Yaktine AL, Valle HBD (eds) Dietary reference intakes for calcium and vitamin D. National Academies Press (US), Washington, DC

    Google Scholar 

  9. Cantorna MT, Zhu Y, Froicu M et al (2004) Vitamin D status, 1,25 dihydroxyvitamin D3, and the immune system. Am J ClinNutr 80(6):1717S–1720S

    CAS  Google Scholar 

  10. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM (2011) Endocrine society. J Clin Endocrinol Metab 96(7):1911–1930

    Article  CAS  PubMed  Google Scholar 

  11. Looker AC, Jhonson CL, Lacher DA, Pfeiffer CM, Schleicher RL, Sempos CT (2001 Mar) Vitamin D status: United states 2001–2006. NCHS Data Brief 59:1–8

    Google Scholar 

  12. Gilsanz V, Kremer A, Mo AO et al (2010) Vitamin D status and its relation to muscle mass and muscle fat in young women. J Clin Endocrinol Metab 95:1595–1601. [PubMed: 20164290]

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Dunlop TW, Vaisanen S, Frank C et al (2005) The human peroxisome proliferator-activated receptor delta gene is a primary target of 1alpha,25-dihydroxyvitamin D3 and its nuclear receptor. J Mol Biol 349:248–260. [PubMed: 15890193]

    Article  CAS  PubMed  Google Scholar 

  14. Maestro B, Campion J, Davila N et al (2000) Stimulation by 1,25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocr J 47:383–391

    Article  CAS  PubMed  Google Scholar 

  15. Draznin B, Sussman K, Kao M et al (1987) The existence of an optimal range of cytosolic free calcium for insulin-stimulated glucose transport in rat adipocytes. J Biol Chem 262:14385–14388. [PubMed: 3312189]

    CAS  PubMed  Google Scholar 

  16. Wei Y, Sowers JR, Clark SE, Li W, Ferrario CM, Stump CS (2008) Angiotensin II- induced skeletal muscle insulin resistance mediated by NF-kappaB activation via NADPH oxidase. Am J Physiol Endocrinol Metab 294:E345–E351

    Article  CAS  PubMed  Google Scholar 

  17. Sergeev IN, Rhoten WB (1995) 1,25-Dihydroxyvitamin D3 evokes oscillations of intracellular calcium in a pancreatic beta-cell line. Endocrinology 136:2852–2861. [PubMed: 7789310]

    Article  CAS  PubMed  Google Scholar 

  18. Billaudel BJ, Faure AG, Sutter BC (1990) Effect of 1,25dihydroxyvitamin D3 on isolated islets from vitamin D3- deprived rats. Am J Phys 258:E643–E648

    CAS  Google Scholar 

  19. Norman AW, Frankel JB, Heldt AM, Grodsky GM (1980) Vitamin D deficiency inhibits pancreatic secretion of insulin. Science 209(4458):823–825

    Article  CAS  PubMed  Google Scholar 

  20. Fujita T, Palmieri GM (2000) Calcium paradox disease: calcium deficiency prompting secondary hyperparathyroidism and cellular calcium overload. J Bone Miner Metab 18:109–125

    Article  CAS  PubMed  Google Scholar 

  21. Sooy K, Schermerhorn T, Noda M et al (1999) Calbindin-D (28k) controls [Ca(2+)](i) and insulin release. Evidence obtained from calbindin-D (28k) knockout mice and beta cell lines. J Biol Chem 274:34343–34349

    Article  CAS  PubMed  Google Scholar 

  22. Kadowaki S, Norman AW (1984) Pancreatic vitamin D-dependent calcium binding protein: biochemical properties and response to vitamin D. Arch Biochem Biophys 233(1):228–236

    Article  CAS  PubMed  Google Scholar 

  23. Cohen-Lahav M, Douvdevani A, Chaimovitz C et al (2007) The anti-inflammatory activity of 1,25- dihydroxyvitamin D3 in macrophages. J Steroid Biochem Mol Biol 103:558–562. [PubMed: 17267205]

    Article  CAS  PubMed  Google Scholar 

  24. Riachy R, Vandewalle B, Moerman E et al (2006) 1,25-Dihydroxyvitamin D3 protects human pancreatic islets against cytokine-induced apoptosis via down-regulation of the Fas receptor. Apoptosis 11:151–159. [PubMed: 16502254]

    Article  CAS  PubMed  Google Scholar 

  25. Gysemans CA, Cardozo AK, Callewaert H et al (2005) 1,25- Dihydroxyvitamin D3 modulates expression of chemokines and cytokines in pancreatic islets: implications for prevention of diabetes in non-obese diabetic mice. Endocrinology 146(4):1956–1964

    Article  CAS  PubMed  Google Scholar 

  26. Tabesh M, Azadbakht L, Faghihimani E, Tabesh M, Esmaillzadeh A (2014) Calcium-vitamin D Cosupplementation influences circulating inflammatory biomarkers and Adipocytokines in vitamin D-insufficient diabetics: a randomized controlled clinical trial. JCEM 99(12):E2485–E2493

    CAS  PubMed  Google Scholar 

  27. Oh JY, Barrett CE (2002) Association between vitamin D receptor polymorphism and type 2 diabetes or metabolic syndrome in community- dwelling older adults: the Rancho Bernardo study. Metabolism 51(3):356–359

    Article  CAS  PubMed  Google Scholar 

  28. Palomer X, Gonzalez-Clemente JM, Blanco-Vaca F, Mauricio D (2008) Role of vitamin D in the pathogenesis of type 2 diabetes mellitus. Diabetes Obes Metab 10(3):185–197

    Article  CAS  PubMed  Google Scholar 

  29. Scragg R, Sowers MF, Bell C (2004) Serum 25-hydroxyvitamin D, diabetes and ethnicity in the third National Health and nutrition examination survey. Diabetes Care 27(12):2813–2818

    Article  CAS  PubMed  Google Scholar 

  30. Hypponen E, Boucher BJ, Berry DJ et al (2008) 25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross sectional study in the 1958 British birth cohort. Diabetes 57(2):298–305

    Article  CAS  PubMed  Google Scholar 

  31. Mattila C, Laaksonen MA, Knekt P et al (2007) Serum 25- hydroxyvitamin D concentration and subsequent risk of type 2 diabetes. Diabetes Care 30(10):2569–2570

    Article  CAS  PubMed  Google Scholar 

  32. Song Y, Wang L, Pittas AG, Liana C (2013) Del Gobo. Blood 25-hydroxy vitamin D levels and incident type 2 diabetes. A meta-analysis of prospective studies. Diabetes Care 36:1422–1428

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Afzal S, Bojesen SE, Nordestgaard BG (2013) Low 25-hydroxyvitamin D and risk of type 2 diabetes: a prospective cohort study and metaanalysis. Clin Chem 59:381–391. [PubMed: 23232064]

    Article  CAS  PubMed  Google Scholar 

  34. McDonnell SL, Baggerly LL, French CB, Heaney RP, Gorham ED, Holick MF, Scragg R, Garland CF (2016) Incidence rate of type 2 diabetes is >50% lower in grassroots health cohort with median serum 25–hydroxyvitamin D of 41 ng/ml than in NHANES cohort with median of 22 ng/ml. J Steroid Biochem Mol Biol 155:239–244

    Article  CAS  PubMed  Google Scholar 

  35. Stadlmayr A, Aigner E, Huber-Schönauer U, Niederseer D, Zwerina J, Husar-Memmer E, Hohla F, Schett G, Patsch W, Datz C (2015) Relations of vitamin D status, gender and type 2 diabetes in middle-aged Caucasians. Acta Diabetol 52:39–46

    Article  CAS  PubMed  Google Scholar 

  36. Pittas AG, Willett WC, Dawson-Hughes B et al (2006) Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 29(3):650–656

    Article  CAS  PubMed  Google Scholar 

  37. Liu S, Song Y, Ford ES, Manson JE, Buring JE, Ridker PM (2005) Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older US women. Diabetes Care 28:2926–2932

    Article  CAS  PubMed  Google Scholar 

  38. Knekt P, Laaksonen M, Mattila C et al (2008) Serum vitamin D and subsequent occurrence of type 2 diabetes. Epidemiology 19(5):666–671

    Article  PubMed  Google Scholar 

  39. Fourohi NG, Luan J, Cooper A et al (2008) Baseline serum 25-hydroxy vitamin D is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely prospective study 1990-2000. Diabetes 57(10):2619–2625

    Article  Google Scholar 

  40. Pittas AG, Harris SS, Stark PC, Wson-Hughes B (2007) The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care 30:980–986

    Article  CAS  PubMed  Google Scholar 

  41. Nazarian S, Peter JVST, Boston RC, Jones SA, Mariash CN (2011) Vitamin D3 supplementation improves insulin sensitivity in subjects with impaired fasting glucose. Transl Res 158(5):276–281

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Mitri J, Dawson-Hughs B, Hu FB, Pittas AG (2011) Effects of viamin D and calcium supplementation on pancreatic beta cell function, insulin sensitivity and glycemia in adults at high risk of diabetes: the calcium and vitamin D for diabetes mellitus (CaDDM) randomized controlled trial. Am J Clin Nutr 94:486–494

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Gagnon C, Daly RM, Carpentier A, Lu ZX, Shore-Lorenti C, Sikaris K, Jean S, Ebeling PR (2014) Effects of combined calcium and vitamin D supplementation on insulin secretion, insulin sensitivity and b-cell function in multi-ethnic vitamin D-deficient adults at risk for type 2 diabetes: a pilot randomized, placebo-controlled trial. PLoS One 9(10):e109607

    Article  PubMed  PubMed Central  Google Scholar 

  44. Zhao L-m, Tian X-q, Ge J-p, Yan-cheng X (2013) Vitamin D intake and type 2 diabetes risk: a meta-analysis of prospective cohort studies. Afr Health Sci 13(4):1130–1138

    Article  PubMed  Google Scholar 

  45. de Boer IH, Tinker LF, Connelly S et al (2008) Calcium plus vitamin D supplementation and the risk of incident diabetes in the Womens health initiative. Diabetes Care 31(4):701–707

    Article  PubMed  PubMed Central  Google Scholar 

  46. Avenell A, Cook JA, MacLennan GS, McPherson GC (2009) Vitamin D supplementation and type 2 diabetes: a substudy of a randomized placebo controlled trial in older people (RECORD trial ISRCTN 51647438). Age Ageing 38:606–609

    Article  PubMed  Google Scholar 

  47. Mitchell DM, Leder BZ, Cagliero E, Mendoza N, Henao MP, Hayden DL, Finkelstein JS, Burnett-Bowie S-AM (2015) Insulin secretion and sensitivity in healthy adults with low vitamin D are not affected by high-dose ergocalciferol administration: a randomized controlled trial. Am J Clin Nutr 102:385–392

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Krul-Poel YHM, Westra S, ten Boekel E, ter Wee MM, van Schoor NM, van Wijland H, Stam F, Lips PTAM, Simsek S (2015 Aug) Effect of vitamin D supplementation on glycemic control in patients with type 2 diabetes (SUNNY trial): a randomized placebo-controlled trial. Diabetes Care 38(8):1420–1426

    Article  CAS  PubMed  Google Scholar 

  49. Elkassaby S, Harrison LC, Mazzitelli N, Wentworth JM, Colman PG, Spelman T, Fourlanos S (2014) A randomised controlled trial of high dose vitamin D in recent-onset type 2 diabetes. Diabetes Res Clin Pract 106:576–582

    Article  CAS  PubMed  Google Scholar 

  50. Tabesh M, Azadbakht L, Faghihimani E, Tabesh M, Esmaillzadeh A (2014) Effects of calcium–vitamin D co-supplementation on metabolic profiles in vitamin D insufficient people with type 2 diabetes: a randomised controlled clinical trial. Diabetologia 57:2038–2047

    Article  CAS  PubMed  Google Scholar 

  51. Kampmann U, Mosekilde L, Juhl C, Moller N, Christensen B, Rejnmark L, Wamberg L, Orskov L (2014) Effects of 12 weeks high dose vitamin D3 treatment on insulin sensitivity, beta cell function, and metabolic markers in patients with type 2 diabetes and vitamin D insufficiency a double-blind, randomized, placebo-controlled trial. Metab Clin Exp 63:1115–1124

    Article  CAS  PubMed  Google Scholar 

  52. Strobel F, Reusch J, Penna-Martinez M, Ramos-Lopez E (2014 Jan) Effect of a randomized controlled vitamin D trial on insulin resistance and glucose metabolism in patients with type 2 diabetes mellitus. Horm Metab Res 46(1):54–58

    CAS  PubMed  Google Scholar 

  53. Nikooyeh B, Neyestani TR, Farvid M, Alavi-Majd H, Houshiarrad A, Kayali A et al (2011) Daily consumption of vitamin D- or vitamin D + calcium- fortified yogurt drink improved glycemic control in patients with type 2 DM: a randomized clinical trial. Am J Clin Nutr 93:764–771

    Article  CAS  PubMed  Google Scholar 

  54. Eftekhari MH, Akbarzadeh M, Dabbaghmanesh MH, Hasanzadeh J (2011) Impact of treatment with oral calcitriol on glucose indices in type 2 diabetes mellitus patients. Am J Clin Nutr 20(4):521–526

    CAS  Google Scholar 

  55. Peng Y, Li L-j (2015) Serum 25-hydroxyvitamin D level and diabetic nephropathy in patients with type 2 diabetes mellitus. Int Urol Nephrol 47:983–989

    Article  CAS  PubMed  Google Scholar 

  56. Wolf M, Shah A, Gutierrez O et al (2007) Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int 72(8):1004–1013

    Article  CAS  PubMed  Google Scholar 

  57. Fernandez-Juarez G, Luno J, BArio V, De Venueza SG (2013 Nov) 25 (OH) vitamin D levels and renal disease progression in patients with type 2 diabetic nephropathy and blockade of the rennin-angiotensin system. Clin J Am Soc Nephrol 8(11):1870–1876

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Zhang Y, Deb DK, Kong J et al (2009) Long-term therapeutic effect of vitamin D analog doxercalciferol on diabetic nephropathy: strong synergism with AT1 receptor antagonist. Am J Physiol Renal Physiol 297(3):F791–F801

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Deb DK, Sun T, Wong KE, Zhang Z, Ning G, Zhang Y et al (2010) Combined vitamin D analog and AT1 receptor antagonist synergistically block the development of kidney disease in a model of type 2 diabetes. Int Soc Nephrol 77:1000–1009

    CAS  Google Scholar 

  60. de Zeeuw D, Agarwal R, Amdahl M, Audhya P, Coyn D, Grimella T (2010) Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diebstes (VITAL study): a randomized controlled trial. Lancet 376:1543–1551

    Article  PubMed  Google Scholar 

  61. Kim MJ, Frankel AH, Donaldson M, Darch SJ, Pusey CD, Hill PD (2011) Oral cholecalciferol decreases albuminuria and urinary TGF-beta 1 in patients with type 2 diabetic nephropathy on established renin-angiotensin-aldostrerone system inhibition. Int Soc Nephrol 80:851–860

    CAS  Google Scholar 

  62. Li YC, Kong J, Wei M et al (2002) 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 110:229–238

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Milliez P, Girerd X, Plouin PF et al (2005) Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 45:1243–1248

    Article  CAS  PubMed  Google Scholar 

  64. Achinger SG, Ayus JC (2005) The role of vitamin D in left ventricular hypertrophy and cardiac function. Kidney Int Suppl 95:S37–S42

    Article  CAS  Google Scholar 

  65. Cardus A, Parisi E, Gallego C et al (2006) 1,25-Dihydroxyvitamin D3 stimulates vascular smooth muscle cell proliferation through a VEGF-mediated pathway. Kidney Int 69:1377–1384

    Article  CAS  PubMed  Google Scholar 

  66. Koenig W, Sund M, Frohlich M et al (1999) C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (monitoring trends and determinants in cardiovascular disease) Augsburg cohort study, 1984 to 1992. Circulation 99:237–242

    Article  CAS  PubMed  Google Scholar 

  67. Kendrick J, Targher G, Smits G, Chonchol M (2009) 25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the third National Health and nutrition examination survey. Atherosclerosis 205:255–260

    Article  CAS  PubMed  Google Scholar 

  68. Yan C, Chun-Ting Z, Zhe Z, Arthur W (2014) Tse hung fat, Yiu Kai hang. Association of myocardial dysfunction with vitamin D deficiency in patients with type 2 diabetes mellitus. J Diabetes Complicat 28:286–290

    Article  Google Scholar 

  69. Herrmann M, Sullivan DR, Veillard A-S, McCorquodale T, Straub IR, Scott R, Laakso M, Topliss D, Jenkins AJ, Blankenberg S, Burton A, Keech AC (2015) Serum 25-Hydroxyvitamin D: a predictor of macrovascular and microvascular complications in patients with type 2 diabetes. Diabetes Care 38:521–528. doi:10.2337/dc14-0180

    Article  CAS  PubMed  Google Scholar 

  70. Heidari B, Nargesi AA, Hafezi-Nejad N, Sheikhbahaei S, Pajouhi A, Nakhjavani M, Esteghamati A (2015) Assessment of serum 25-hydroxy vitamin D improves coronary heart disease risk stratification in patients with type 2 diabetes. Am Heart J 170:573–579.e5

    Article  CAS  PubMed  Google Scholar 

  71. Witham MD, Dove FJ, Dryburgh M, Sigden JA, Morris AD, Struthers AD (2010) The effecr of different doses of vitamin D3 on markers of vascular health in patients with type 2 diabetes: a randomized controlled trial. Diabetologia 53:2112–2119

    Article  CAS  PubMed  Google Scholar 

  72. Sugden JA, Davies JI, Witham MD, Mrrist AD, Struthers AD (2008) Vitamin D improves endothelial function in patients with type 2 diabetes mellitus and low vitamin D levels. Diabet Med 25:320–325

    Article  CAS  PubMed  Google Scholar 

  73. Soderstrom LH, Johnson SP (2012) Diaz1VA and Mainous AG 3rd. Association between vitamin D and diabetic neuropathy in a nationally representative sample: results from 2001–2004 NHANES. Diabet Med 29:50–55

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  74. Shehab D, Al-Jarallah K, Mojiminiyi OA, Al Mohamedy H, Abdella NA (2012) Does vitamin D deficiency play a role in peripheral neuropathy in type 2 diabetes? Diabet Med 29:43–49

    Article  CAS  PubMed  Google Scholar 

  75. Ahmadieh H, Azar ST, Lakkis N, Arabi A (2013) Hypovitaminosis D in patients with type 2 diabetes mellitus: a relation to disease control and complications. ISRN Endocrinol 22(2013):641098

    Google Scholar 

  76. Lee P, Chen R (2008) Vitamin D as an analgesic for patients with type 2 diabetes and neuropathic pain. Arch Intern Med 168:771–772

    Article  PubMed  Google Scholar 

  77. Shehab D, Al-Jarallah K, Abdella N, Olusegun A, Mojiminiyi HAM (2015) Prospective evaluation of the effect of short-term oral vitamin D supplementation on peripheral neuropathy in type 2 diabetes mellitus. Med Princ Pract 24:250–256. doi:10.1159/000375304

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  78. Aksoy H, Akçay F, Kurtul N, Baykal O, Avci B (2000) Serum 1,25Dihydroxy vitamin D (1,25(OH)2D3), 25 Hydroxy vitamin D (25(OH)D) and Parathormone levels in diabetic retinopathy. Clin Biochem 33(1):47–51

    Article  CAS  PubMed  Google Scholar 

  79. Alcubierre N, Valls J, Rubinat E, Cao G, Esquerda A, Traveset A, Granado-Casas M, Jurjo C, Mauricio D (2015) Vitamin D deficiency is associated with the presence and severity of diabetic retinopathy in type 2 diabetes mellitus. J Diabetes Res, Article ID 374178, p 7. http://dx.doi.org/10.1155/2015/374178

    Google Scholar 

  80. Bhanuprakash Reddy G, Sivaprasad M, Shalini T, Satyanarayana A, Seshacharyulu M, Balakrishna N, Viswanath K, Sahay M (2015) Plasma vitamin D status in patients with type 2 diabetes with and without retinopathy. Nutrition 31:959–963

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Endocrinology Consultant, Ain Wazein Medical Village, Lebanon- Mount of Lebanon-Shouf Area, Lebanon, PA, Lebanon

    Claire Michael Issa

Authors
  1. Claire Michael Issa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Claire Michael Issa .

Editor information

Editors and Affiliations

  1. Faculty of Science and Technology, Nottingham Trent University, Nottingham, United Kingdom

    Shamim I. Ahmad

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Issa, C.M. (2017). Vitamin D and Type 2 Diabetes Mellitus. In: Ahmad, S. (eds) Ultraviolet Light in Human Health, Diseases and Environment. Advances in Experimental Medicine and Biology, vol 996. Springer, Cham. https://doi.org/10.1007/978-3-319-56017-5_16

Download citation

Publish with us

Policies and ethics

Search

Navigation